These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1034 related items for PubMed ID: 22520044

  • 1. [Prostatic involvement by urothelial carcinoma in patients with bladder cancer and their implications in the clinical practice].
    Huguet J.
    Actas Urol Esp; 2012 Oct; 36(9):545-53. PubMed ID: 22520044
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Urothelial carcinoma in the prostatic urethra and prostate: current controversies.
    Liedberg F, Chebil G, Månsson W.
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):383-90. PubMed ID: 17338657
    [Abstract] [Full Text] [Related]

  • 4. Long-term follow-up of intravesical bacillus Calmette-Guérin treatment for superficial transitional-cell carcinoma of the bladder involving the prostatic urethra.
    Taylor JH, Davis J, Schellhammer P.
    Clin Genitourin Cancer; 2007 Sep; 5(6):386-9. PubMed ID: 17956711
    [Abstract] [Full Text] [Related]

  • 5. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.
    Huguet J, Crego M, Sabaté S, Salvador J, Palou J, Villavicencio H.
    Eur Urol; 2005 Jul; 48(1):53-9; discussion 59. PubMed ID: 15967252
    [Abstract] [Full Text] [Related]

  • 6. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    Solsona E, Iborra I, Ricos JV, Monros JL, Rubio J, Almenar S.
    J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prediction of prostatic involvement by urothelial carcinoma in radical cystoprostatectomy for bladder cancer.
    Mazzucchelli R, Barbisan F, Santinelli A, Scarpelli M, Galosi AB, Lopez-Beltran A, Cheng L, Kirkali Z, Montironi R.
    Urology; 2009 Aug; 74(2):385-90. PubMed ID: 19501882
    [Abstract] [Full Text] [Related]

  • 9. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
    Solsona E, Iborra I, Rubio J, Casanova J, Almenar S.
    BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Incidental prostate cancer in patients with bladder urothelial carcinoma: comprehensive analysis of 1,476 radical cystoprostatectomy specimens.
    Bruins HM, Djaladat H, Ahmadi H, Sherrod A, Cai J, Miranda G, Skinner EC, Daneshmand S.
    J Urol; 2013 Nov; 190(5):1704-9. PubMed ID: 23707451
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion.
    Esrig D, Freeman JA, Elmajian DA, Stein JP, Chen SC, Groshen S, Simoneau A, Skinner EC, Lieskovsky G, Boyd SD, Cote RJ, Skinner DG.
    J Urol; 1996 Sep; 156(3):1071-6. PubMed ID: 8709310
    [Abstract] [Full Text] [Related]

  • 15. Prospective study of transitional cell carcinoma in the prostatic urethra and prostate in the cystoprostatectomy specimen. Incidence, characteristics and preoperative detection.
    Liedberg F, Anderson H, Bläckberg M, Chebil G, Davidsson T, Gudjonsson S, Jahnson S, Olsson H, Månsson W.
    Scand J Urol Nephrol; 2007 Sep; 41(4):290-6. PubMed ID: 17763219
    [Abstract] [Full Text] [Related]

  • 16. [Urethral recurrence of invasive carcinoma following BCG treatment for bladder Ca in situ].
    Ruoppolo M, Gozo M, Milesi R, Spina R, Fragapane G.
    Urologia; 2010 Sep; 77 Suppl 17():72-7. PubMed ID: 21308679
    [Abstract] [Full Text] [Related]

  • 17. The risk factor for urethral recurrence after radical cystectomy in patients with transitional cell carcinoma of the bladder.
    Cho KS, Seo JW, Park SJ, Lee YH, Choi YD, Cho NH, Yang SC, Hong SJ.
    Urol Int; 2009 Sep; 82(3):306-11. PubMed ID: 19440019
    [Abstract] [Full Text] [Related]

  • 18. Intravesical instillations with bacillus calmette-guérin for the treatment of carcinoma in situ involving prostatic ducts.
    Palou Redorta J, Schatteman P, Huguet Pérez J, Segarra Tomás J, Rosales Bordes A, Algaba F, Villavicencio Mavrich H.
    Eur Urol; 2006 May; 49(5):834-8; discussion 838. PubMed ID: 16426729
    [Abstract] [Full Text] [Related]

  • 19. [Radical cystectomy in patients with non-muscle invasive bladder cancer who fail BCG therapy].
    Huguet J, Gaya JM, Sabaté S, Palou J, Villavicencio H.
    Actas Urol Esp; 2010 Jan; 34(1):63-70. PubMed ID: 20223134
    [Abstract] [Full Text] [Related]

  • 20. Developing selection criteria for prostate-sparing cystectomy: a review of cystoprostatectomy specimens.
    Richards KA, Parks GE, Badlani GH, Kader AK, Hemal AK, Pettus JA.
    Urology; 2010 May; 75(5):1116-20. PubMed ID: 20080289
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.